SAB Biotherapeutics, Inc. - Common Stock
SAB Biotherapeutics, Inc. - Common Stock
Share · US78397T2024 · SABS (XNAS)
Overview Financial Indicators
1,72 USD
-6,06 % -0,11 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 19:59

Current Prices from SAB Biotherapeutics, Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
SABS
USD
13.06.2025 19:59
1,72 USD
1,83 USD
-6,06 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -4,44 % -8,36 % 10,97 % -58,15 % -46,75 % -98,31 %

Company Profile for SAB Biotherapeutics, Inc. - Common Stock Share

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.

Company Data

Name SAB Biotherapeutics, Inc. - Common Stock
Company SAB Biotherapeutics, Inc.
Symbol SABS
Website https://www.sabbiotherapeutics.com
Primary Exchange XNAS NASDAQ
ISIN US78397T2024
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Samuel J. Reich
Market Capitalization 13 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 2100 East 54th Street North, 57104 Sioux Falls
IPO Date 2021-02-09

ID Changes

Date From To
25.10.2021 BCYP SABS

Ticker Symbols

Name Symbol
NASDAQ SABS

More Shares

Investors who SAB Biotherapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:
NORDLB 25/27
NORDLB 25/27 Bond
SCBC 17/24 MTN
SCBC 17/24 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025